Your browser is no longer supported. Please, upgrade your browser.
Settings
BSX Boston Scientific Corporation daily Stock Chart
BSX [NYSE]
Boston Scientific Corporation
IndexS&P 500 P/E87.28 EPS (ttm)0.31 Insider Own0.30% Shs Outstand1.37B Perf Week3.45%
Market Cap37.33B Forward P/E19.31 EPS next Y1.42 Insider Trans-9.91% Shs Float1.36B Perf Month4.35%
Income435.00M PEG8.43 EPS next Q0.31 Inst Own93.90% Short Float1.11% Perf Quarter10.12%
Sales8.58B P/S4.35 EPS this Y241.40% Inst Trans0.46% Short Ratio2.24 Perf Half Y30.22%
Book/sh5.17 P/B5.28 EPS next Y13.47% ROA2.40% Target Price29.41 Perf Year21.10%
Cash/sh0.11 P/C239.29 EPS next 5Y10.36% ROE6.60% 52W Range19.67 - 27.39 Perf YTD26.31%
Dividend- P/FCF97.72 EPS past 5Y-2.80% ROI5.10% 52W High-0.26% Beta1.07
Dividend %- Quick Ratio0.60 Sales past 5Y1.90% Gross Margin71.30% 52W Low38.89% ATR0.38
Employees27000 Current Ratio0.90 Sales Q/Q10.00% Oper. Margin6.00% RSI (14)70.05 Volatility1.44% 1.26%
OptionableYes Debt/Eq0.78 EPS Q/Q41.50% Profit Margin5.10% Rel Volume0.71 Prev Close27.26
ShortableYes LT Debt/Eq0.78 EarningsApr 27 BMO Payout0.00% Avg Volume6.72M Price27.32
Recom1.90 SMA203.15% SMA507.42% SMA20015.21% Volume4,801,857 Change0.22%
May-16-17Initiated Goldman Neutral $28
Apr-28-17Reiterated Needham Buy $29 → $30
Feb-03-17Reiterated Needham Buy $28 → $29
Sep-01-16Upgrade Argus Hold → Buy
Jul-29-16Reiterated Wedbush Neutral $23 → $25
Jul-29-16Reiterated Needham Buy $26 → $28
Jul-28-16Reiterated The Benchmark Company Buy $25 → $31
Jun-09-16Initiated Guggenheim Buy
Apr-28-16Reiterated Wedbush Neutral $19 → $23
Apr-28-16Reiterated Stifel Buy $22 → $25
Apr-28-16Reiterated RBC Capital Mkts Outperform $22 → $25
Apr-28-16Reiterated Barclays Overweight $23 → $25
Apr-27-16Reiterated The Benchmark Company Buy $20 → $22
Apr-12-16Reiterated RBC Capital Mkts Outperform $20 → $22
Mar-17-16Initiated Nomura Buy
Feb-25-16Initiated Sun Trust Rbsn Humphrey Buy $21
Nov-12-15Initiated Citigroup Buy
Oct-28-15Reiterated Needham Buy $21 → $22
Oct-05-15Upgrade Raymond James Outperform → Strong Buy
Sep-28-15Upgrade Needham Hold → Buy $21
May-26-17 04:35PM  How BSXs Lotus Recall Developments Impacted Its Share Price Market Realist
03:06PM  Boston Scientific Completes Its Acquisition of Symetis Market Realist
01:14PM  Discussing Boston Scientific Stocks Recent Movements Market Realist
07:37AM  St. Jude Medical May Establish ABT as a Key Medical Device Player Market Realist
May-25-17 03:54PM  Analysts Recommendations for Abbott Laboratories in May 2017 Market Realist
02:36PM  Is Medical Technology Driving the US Healthcare Industry? Market Realist
11:29AM  Medtronic's focus on surgical products fuels profit beat Reuters
10:06AM  Boston Scientific (BSX) BT Study on Asthma Results Positive Zacks
08:36AM  Medtronic Tops Views On Q4 Sales, Earnings Investor's Business Daily
May-24-17 05:03PM  Michael Price Buys Banc of California, FMC, Boston Scientific GuruFocus.com
09:15AM  Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty PR Newswire
May-23-17 12:52AM  [$$] Companies Are Winning the Battle Over Adjusted Earnings The Wall Street Journal
May-22-17 08:00AM  [$$] Companies Winning the Battle Over Adjusted Earnings The Wall Street Journal
May-19-17 04:45PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
03:28PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
12:11PM  Boston Scientific In Buy Zone, Gets Stock Rating Upgrade Investor's Business Daily
May-18-17 09:32AM  Boston Scientific's Symetis Buyout Boosts Structural Heart Zacks
May-17-17 09:25AM  Boston Scientific Hits a 52-Week High on Solid Prospects Zacks
09:00AM  Boston Scientific to Participate in 2017 UBS Global Healthcare Conference PR Newswire
08:15AM  Blog Coverage: Boston Scientific Completes Symetis Acquisition; Views TAVI Portfolio Expansion through the Agreement Accesswire
May-16-17 04:29PM  Boston's Heart Valve Wins In Face-Off Trial With Rival Medtronic Investor's Business Daily
06:47AM  The Boston Scientific LOTUS Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year PR Newswire
01:15AM  Boston Scientific Closes Symetis Acquisition PR Newswire
May-12-17 12:23PM  Boston Scientific Announces Positive European Registry Results For WATCHMAN Left Atrial Appendage Closure Device PR Newswire
12:15PM  New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints PR Newswire
May-11-17 01:02PM  Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients PR Newswire
May-10-17 08:15AM  Blog Coverage: FDA Approves Boston Scientific's Resonate Family of High-Voltage Devices Accesswire
02:30AM  Boston Scientific Announces Schedule of Presentations at EuroPCR 2017 PR Newswire
May-09-17 12:47PM  India government panel rejects Boston Scientific plea on stent price caps Reuters
10:35AM  Behind Boston Scientifics Recent Stock Performance Market Realist
09:06AM  What Will Drive Boston Scientifics Updated 2017 Guidance? Market Realist
07:36AM  Inside Boston Scientifics Acquisition of Symetis: The Must-Know Details Market Realist
07:30AM  Cramer: These Sectors Look Bullish (Part III) TheStreet.com
06:30AM  Boston Scientific Receives U.S. FDA Approval For Resonate Family Of High-Voltage Devices PR Newswire
May-08-17 10:36AM  Understanding Boston Scientifics Key Growth Drivers for MedSurg Market Realist
09:07AM  What Dragged down BSXs 1Q17 Margins? Market Realist
07:38AM  Your Highlights of Boston Scientifics 1Q17 Earnings Market Realist
May-05-17 05:57PM  Inside the Latest Analyst Recommendations for Boston Scientific Market Realist
May-04-17 02:25PM  Boston Scientific is the 2nd biggest dealmaker in medtech since 2012 American City Business Journals
May-03-17 04:30PM  Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017 PR Newswire
May-01-17 08:30AM  Boston Scientific to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference PR Newswire
Apr-28-17 09:20PM  Edited Transcript of BSX earnings conference call or presentation 27-Apr-17 12:00pm GMT Thomson Reuters StreetEvents
08:51AM  Global med-tech firms, India locked in tussle after stent price sting Reuters
Apr-27-17 10:36AM  Boston Scientific (BSX) Misses on Q1 Earnings, Updates View Zacks
08:08AM  Boston Scientific (BSX): Beats on Q1 Sales, Misses Earnings Zacks
06:37AM  Boston Scientific misses 1Q profit forecasts Associated Press
06:30AM  Boston Scientific Announces Results For First Quarter 2017 PR Newswire
Apr-26-17 04:35PM  Edwards Rockets To 6-Month High On Strong U.S. Heart-Valve Sales Investor's Business Daily
Apr-24-17 01:34PM  Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead TheStreet.com
Apr-21-17 03:24PM  Boston Scientific Corp. Value Analysis (NYSE:BSX) : April 21, 2017 Capital Cube
08:33AM  Will Boston Scientific (BSX) Surprise this Earnings Season? Zacks
Apr-20-17 08:21AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : April 20, 2017 Capital Cube
Apr-18-17 04:15PM  Boston Scientific Initiates Global Study To Assess Sudden Cardiac Arrest Prevention Therapy In Patients With Diabetes Who Have Previously Experienced A Heart Attack PR Newswire
Apr-17-17 12:09PM  Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock TheStreet.com
Apr-13-17 03:01PM  Boston Scientific's Emerging Markets Grow Amid Currency Woes Zacks
Apr-07-17 07:30AM  Today's Research Reports on Stocks to Watch: Boston Scientific and Medtronic Accesswire
Apr-03-17 07:35AM  5 Trade Ideas for Boston Scientific: Bonus Idea
Mar-31-17 01:52PM  Boston Scientific (BSX) Inks Agreement to Acquire Symetis SA Zacks
09:27AM  Boston Scientific Buys Symetis for $435 Million at Investopedia
Mar-30-17 05:16PM  Boston Scientific Corporation -- Moody's: Boston Scientific's Symetis Acquisition is Credit Positive Moody's
05:16PM  Boston Scientific Corporation -- Moody's: Boston Scientific's Symetis Acquisition is Credit Positive at Moody's
04:25PM  Boston Scientific Makes Acquisition To Battle Medtronic, Edwards Investor's Business Daily
04:25PM  Boston Scientific Makes Acquisition To Battle Medtronic, Edwards
11:50AM  Boston Scientific to expand in Europe with Symetis buy Reuters
09:00AM  Boston Scientific To Webcast Conference Call Discussing First Quarter 2017 Financial Results And Announces Revised Date For 2017 Investor Day PR Newswire
06:16AM  Boston Scientific to acquire Symetis for $435 mln
06:08AM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  Boston Scientific Announces Agreement to Acquire Symetis PR Newswire
Mar-29-17 10:00AM  Boston Scientific's CEO got $36 million in compensation, stock value last year at bizjournals.com
10:00AM  Boston Scientific's CEO got $36 million in compensation, stock value last year American City Business Journals
Mar-28-17 08:09AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : March 28, 2017 Capital Cube
08:09AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : March 28, 2017
Mar-27-17 05:07PM  Medtronic, Edwards Among Five Best 'Stocks To Own': Analyst
Mar-17-17 04:32PM  Medtronic Does Heart-Valve Study, And Rivals Reap The Benefits Investor's Business Daily
04:32PM  Medtronic Does Heart-Valve Study, And Rivals Reap The Benefits
08:17AM  Boston Scientific Corp. breached its 50 day moving average in a Bearish Manner : BSX-US : March 17, 2017
Mar-16-17 09:16PM  NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure PR Newswire
Mar-13-17 04:36PM  U.S. medtech shares gain as investors seek shelter from drug price debate
Mar-10-17 02:29PM  German Court Rules In Favor Of Boston Scientific Corporation (BSX) In Patent Case Against Edwards Lifesciences Corp (EW) at Insider Monkey
09:25AM  Boston Scientific and Edwards Lifesciences Are in a Patent Battle
08:15AM  Blog Coverage German and UK Courts Rule in Favor of Boston Scientifics' Patent Related Litigation with Edwards Lifesciences Accesswire
Mar-09-17 04:49PM  Boston Scientific Wins In Patent Battle Vs. Edwards In German Court
04:59AM  Boston Scientific Receives Favorable Rulings In Edwards Lifesciences Litigation PR Newswire
Mar-07-17 08:30AM  Boston Scientific To Participate In Barclays Global Healthcare Conference PR Newswire
06:30AM  At Boston Scientific, device tax reprieve spurs mostly ex-U.S. job growth at bizjournals.com
Mar-03-17 07:00AM  Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics PR Newswire
Mar-01-17 01:04PM  BOSTON SCIENTIFIC CORP Financials
Feb-24-17 01:03PM  Boston Scientific Corporation (BSX) Lotus Transcatheter Recalled After Discovery Of Fault And Death Of One Patient at Insider Monkey
11:15AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Boston Scientific Corporation and Advises Investors with Losses to Contact the Firm Business Wire
11:10AM  Boston Scientific Recalls Lotus Heart Devices at Investopedia
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Boston Scientific Corporation Investors Business Wire
Feb-23-17 11:59PM  [$$] Boston Scientific Recalls Lotus Heart Valve Device at The Wall Street Journal
11:25PM  Asian stocks fall amid Trump trade policy fears, strong yen AP
06:51PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Boston Scientific Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
04:33PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Boston Scientific Corporation Investors Business Wire
04:09PM  Boston Topples On Heart Valve Bug; 'Woes' Boost Edwards, Medtronic
01:28PM  Boston Scientific sinks on heart valve system recall
12:58PM  [$$] Boston Scientific Recalls Lotus Heart Valve Device at The Wall Street Journal
12:29PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Boston Scientific Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
11:52AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Boston Scientific Corp. (BSX) PR Newswire
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ballinger Kevin J.EVP & Pres, Interven CardioMay 17Sale26.1428,864754,45457,366May 18 04:25 PM
Phalen Michael P.EVP & President, MedSurgMay 01Option Exercise7.1615,500110,980117,419May 02 04:11 PM
Phalen Michael P.EVP & President, MedSurgMay 01Sale26.3715,500408,778101,919May 02 04:11 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMay 01Sale26.3710,000263,728225,846May 02 04:11 PM
Pierce David ASVP and President, EndoscopyApr 26Option Exercise7.3910,25075,74835,850Apr 27 04:10 PM
Phalen Michael P.EVP & President, MedSurgApr 26Option Exercise12.5234,773435,358136,692Apr 27 04:10 PM
Pierce David ASVP and President, EndoscopyApr 26Sale26.0010,250266,50025,600Apr 27 04:10 PM
Phalen Michael P.EVP & President, MedSurgApr 26Sale26.0034,773904,098101,919Apr 27 04:10 PM
Sorenson John BradleySVP, Manuf & Sup ChnApr 10Sale24.662,95072,74720,980Apr 11 04:11 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 03Sale24.8710,000248,725235,846Apr 04 04:09 PM
Phalen Michael P.EVP & President, MedSurgMar 29Option Exercise7.1646,500332,940180,964Mar 30 04:37 PM
Phalen Michael P.EVP & President, MedSurgMar 29Sale24.5579,0451,940,341101,919Mar 30 04:37 PM
Pierce David ASVP and President, EndoscopyMar 03Sale25.0125,012625,66825,600Mar 03 05:50 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMar 03Sale25.0123,540588,846245,846Mar 03 05:50 PM
Mackey Edward FEVP, OperationsMar 02Option Exercise0.0019,226037,058Mar 03 05:50 PM
Ballinger Kevin J.EVP & Pres, Interven CardioFeb 28Option Exercise0.005,7510101,143Mar 01 08:54 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 28Option Exercise0.003,3830219,923Mar 01 08:56 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 28Option Exercise0.003,383015,201Mar 01 08:55 PM
Brennan Daniel J.EVP and CFOFeb 28Option Exercise0.002,7060243,212Mar 01 08:55 PM
Bose SupratimEVP & President, Asia-PacificFeb 28Option Exercise0.006,7660320,301Mar 01 08:55 PM
Phalen Michael P.EVP & President, MedSurgFeb 28Option Exercise0.005,4130151,678Mar 01 08:56 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 28Option Exercise0.004,7360110,120Mar 02 07:17 PM
Mahoney Michael FChairman, President & CEOFeb 28Option Exercise0.0050,74402,013,705Mar 02 07:23 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.003,7210134,559Mar 02 07:21 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 28Option Exercise0.005,4130110,714Mar 02 07:29 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 28Option Exercise0.005,413025,749Mar 02 07:29 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 28Option Exercise0.008,4570294,948Mar 02 07:28 PM
Pierce David ASVP and President, EndoscopyFeb 28Option Exercise0.004,398064,794Mar 02 07:28 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 28Option Exercise0.006,0890166,059Mar 02 07:30 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Option Exercise0.003,7210114,505Mar 02 07:34 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 28Sale24.6430,000739,13468,165Mar 02 07:17 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Sale24.6725,000616,66378,675Mar 02 07:34 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 27Option Exercise0.009,5550248,758Feb 28 05:59 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 27Option Exercise0.007,166022,734Feb 28 05:59 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 27Option Exercise0.004,3000106,247Feb 28 05:59 PM
Pierce David ASVP and President, EndoscopyFeb 27Option Exercise0.003,185034,267Feb 28 05:58 PM
Brennan Daniel J.EVP and CFOFeb 27Option Exercise0.002,5880184,386Feb 28 05:57 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 27Option Exercise0.002,548012,996Feb 28 05:57 PM
Carruthers WendySVP, Human ResourcesFeb 27Option Exercise0.004,6180107,491Feb 28 05:58 PM
Mahoney Michael FChairman, President & CEOFeb 27Option Exercise0.0057,32501,699,415Feb 28 05:58 PM
Pierce David ASVP and President, EndoscopyFeb 27Sale24.843,41784,88329,816Feb 28 05:58 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 27Sale24.844,832120,034240,621Feb 28 05:59 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 24Option Exercise0.001,529016,068Feb 27 05:29 PM
Pierce David ASVP and President, EndoscopyFeb 24Option Exercise0.003,058032,075Feb 27 05:28 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 24Option Exercise0.001,5290102,284Feb 27 05:29 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 24Option Exercise0.004,5870240,692Feb 27 05:29 PM
Phalen Michael P.EVP & President, MedSurgFeb 24Option Exercise0.003,4400108,678Feb 27 04:30 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 24Option Exercise0.002,293080,086Feb 27 04:28 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 24Option Exercise0.004,7780109,829Feb 27 04:28 PM
Mahoney Michael FChairman, President & CEOFeb 24Option Exercise0.0029,05201,655,759Feb 27 04:29 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 24Option Exercise0.002,485085,187Feb 27 04:29 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 24Option Exercise0.002,6760189,297Feb 27 04:29 PM
Bose SupratimEVP & President, Asia-PacificFeb 24Option Exercise0.002,6760283,592Feb 27 04:27 PM
Brennan Daniel J.EVP and CFOFeb 24Option Exercise0.005,7340183,958Feb 27 04:27 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 24Option Exercise0.001,338011,114Feb 27 04:27 PM
Carruthers WendySVP, Human ResourcesFeb 24Option Exercise0.002,4850103,680Feb 27 04:28 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 24Option Exercise0.002,867065,574Feb 27 04:27 PM
Phalen Michael P.EVP & President, MedSurgFeb 23Option Exercise0.002,4520106,034Feb 24 05:22 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 23Option Exercise0.009190100,958Feb 24 05:21 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 23Option Exercise0.001,533015,121Feb 24 05:21 PM
Pierce David ASVP and President, EndoscopyFeb 23Option Exercise0.002,452029,813Feb 24 04:28 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 23Option Exercise0.003,6780237,299Feb 24 04:28 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 23Option Exercise0.002,146083,424Feb 24 04:22 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 23Option Exercise0.001,8390187,313Feb 24 04:22 PM
Mahoney Michael FChairman, President & CEOFeb 23Option Exercise0.0023,75801,637,886Feb 24 04:21 PM
Mackey Edward FEVP, OperationsFeb 23Option Exercise0.002,299018,559Feb 24 04:20 PM
Carruthers WendySVP, Human ResourcesFeb 23Option Exercise0.002,4520101,991Feb 24 04:19 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 23Option Exercise0.004,1380106,442Feb 24 04:20 PM
Brennan Daniel J.EVP and CFOFeb 23Option Exercise0.005,3650179,965Feb 24 04:19 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 23Option Exercise0.001,073010,338Feb 24 04:19 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 23Option Exercise0.001,839078,624Feb 24 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 23Option Exercise0.003,678063,943Feb 24 04:18 PM
Bose SupratimEVP & President, Asia-PacificFeb 23Option Exercise0.002,1460280,916Feb 24 04:18 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 22Option Exercise0.001,8820186,182Feb 23 06:41 PM
Phalen Michael P.EVP & President, MedSurgFeb 22Option Exercise0.002,4620104,381Feb 23 06:41 PM
Butcher Arthur CSVP&Pres, EndoscopyFeb 22Option Exercise0.001,01309,796Feb 23 06:40 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 22Option Exercise0.004,0550103,667Feb 23 06:40 PM
Carruthers WendySVP, Human ResourcesFeb 22Option Exercise0.002,3170100,291Feb 23 05:21 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 22Option Exercise0.001,738077,602Feb 23 05:24 PM
Brennan Daniel J.EVP and CFOFeb 22Option Exercise0.005,7930176,480Feb 23 05:10 PM
Bose SupratimEVP & President, Asia-PacificFeb 22Option Exercise0.002,1720278,770Feb 23 05:05 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 22Option Exercise0.003,765061,531Feb 23 05:00 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 22Option Exercise0.002,0270100,485Feb 23 06:43 PM
Pierce David ASVP and President, EndoscopyFeb 22Option Exercise0.002,607028,207Feb 23 06:42 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 22Option Exercise0.003,4760234,749Feb 23 06:42 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 22Option Exercise0.001,593014,208Feb 23 06:42 PM
Mackey Edward FEVP, OperationsFeb 22Option Exercise0.002,896017,302Feb 23 06:41 PM
Mahoney Michael FChairman, President & CEOFeb 22Option Exercise0.0023,17401,625,032Feb 23 06:41 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 22Option Exercise0.002,317082,057Feb 23 06:41 PM
Dawkins Keith DEVP, Global Chief Med. Off.Feb 07Sale25.2180,7832,036,52375,864Feb 08 04:24 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 06Sale24.9423,775592,85898,458Feb 08 04:24 PM
Pierce David ASVP and President, EndoscopyJan 09Sale22.2410,232227,54625,600Jan 10 04:08 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 09Sale22.246,195137,769231,273Jan 10 04:06 PM
Bose SupratimEVP & President, Asia-PacificJan 03Option Exercise0.0014,9260276,598Jan 05 05:07 PM
Phalen Michael P.EVP & President, MedSurgJan 01Option Exercise0.0017,5100107,596Jan 04 04:40 PM
Pierce David ASVP and President, EndoscopyJan 01Option Exercise0.0015,565041,165Jan 04 04:40 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 01Option Exercise0.0023,3470245,326Jan 04 04:40 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventJan 01Option Exercise0.0012,646084,271Jan 04 04:30 PM
Nanavaty MaulikSVP & Pres, NeuromodulationJan 01Option Exercise0.0013,6190189,746Jan 04 04:30 PM
Mahoney Michael FPresident & CEOJan 01Option Exercise0.00147,87301,664,964Jan 04 04:26 PM